Skip to main content
. Author manuscript; available in PMC: 2021 Sep 24.
Published in final edited form as: Nat Med. 2021 Jan 4;27(1):58–65. doi: 10.1038/s41591-020-1126-7

Fig. 2: Propensity score matching and association of brown fat with medication, cancer site and cancer treatment.

Fig. 2:

a, PSM was used to identify a matched cohort based on age, sex, BMI and outdoor temperature in the month of the index scan. b, Forest plots illustrate the association between brown fat status and use of antihypertensive drugs and statins in the propensity score-matched cohort. Circles and bars represent ORs and 95% CIs, respectively. c, Forest plots illustrate the association between brown fat status and site of neoplasm (based on ICD-O codes) in the propensity score-matched cohort. Circles and bars represent ORs and 95% CIs, respectively. d, Forest plots illustrate the association between brown fat status and cancer treatment in the propensity score-matched cohort. Circles and bars represent ORs and 95% CIs, respectively. ACE, angiotensin-converting enzyme; ARB, angiotensin II receptor blocker; CCB, calcium channel blocker.